Haemonetics (HAE) Misses Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $76.89 --0%
EPS Growth %: -0.9%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: -0.9%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.37, $0.09 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $243.2 million versus the consensus estimate of $245.08 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
- Barclays says SK Hynix stock could more than double on ’significant growth’
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
